Androgen-dependent diseases eg, acne, especially pronounced forms & accompanied by seborrhea or inflammation or formation of nodes (acne papulopustulosa, acne nodulocystica), androgenetic alopecia & mild forms of hirsutism.
View Faye overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Presence or history of venous or arterial thrombotic/thromboembolic events or CVA, prodomi of thrombosis; severe or multiple risk factors for venous or arterial thrombosis; history of migraine w/ focal neurological symptoms; DM w/ vascular involvement; pancreatitis or history associated w/ severe hypertriglyceridemia; presence or history of liver tumors (benign/malignant); known/suspected sex-steroid influenced malignancies; undiagnosed vag bleeding. Not for use in men. Severe hepatic disease. Known or suspected pregnancy. Lactation.
Increased risk of arterial & venous thrombotic & thromboembolic diseases (eg, MI, DVT, pulmonary embolism & CVA), patients w/ CVA, HTN, hypertriglyceridemia; smoking patients; increased frequency/severity of migraine, changes in glucose tolerance or effect on peripheral insulin resistance; liver tumours (benign & malignant); chloasma. Periodic medical assessment for contraindications (eg, transient ischaemic attack) or risk factors (eg, family history of venous or arterial thrombosis), irregular bleeding may occur. Acute/chronic liver function disturbances. Not indicated during pregnancy & lactation.
G03HB01 - cyproterone and estrogen ; Belongs to the class of antiandrogen preparations in combination with estrogens. Used to counter androgenic activities.
Sign Out
